Cargando…
Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases
There are more than 100 autoimmune diseases (AD), which have a high prevalence that ranges between 5% and 8% of the general population. Type I diabetes mellitus, multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis remain the health problem of highest concern among people worldw...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818563/ https://www.ncbi.nlm.nih.gov/pubmed/35146402 http://dx.doi.org/10.1016/j.jtauto.2022.100146 |